
    
      Patients with histological documented non-small cell lung cancer, that are considered to be
      inoperable, meet all the eligibility criteria, and sign informed consent will be treated with
      one cycle of irinotecan and cisplatin, followed by three additional cycles of chemotherapy
      with 60 - 70 Gy of concurrent radiation therapy.
    
  